The primary objective of this study was to investigate the difference in the 5-year survival between the NPC1L1 high and NPC1L1 low groups because this parameter is widely used to reflect the prognosis—and the endeavors required for the clinical management—of cancer. Here, NPC1L1 is linked to cancer.